Skip to main content
Top

Current Cardiology Reports

Issue 3/2014

Content (10 Articles)

Duodenal-Jejunal Bypass Liner to Treat Type 2 Diabetes Mellitus in Morbidly Obese Patients

  • Diabetes and Cardiovascular Disease (S Malik, Section Editor)

Rodrigo Muñoz, Alex Escalona

Statin Treatment, New-Onset Diabetes, and Other Adverse Effects: A Systematic Review

  • Diabetes and Cardiovascular Disease (S Malik, Section Editor)

Casper N. Bang, Peter M. Okin

Current State of Anticoagulants to Treat Deep Venous Thrombosis

  • Peripheral Vascular Disease (MH Shishehbor, Section Editor)

Timothy Vo, Sara Vazquez, Matthew T. Rondina

Management of Symptomatic Carotid Disease in 2014

  • Peripheral Vascular Disease (MH Shishehbor, Section Editor)

Jason Litsky, Erik Stilp, Roland Njoh, Carlos Mena-Hurtado

Guidance of Post Myocardial Infarction Ventricular Septal Defect and Pseudoaneurysm Closure

  • Echocardiography (RM Lang, Section Editor)

Itzhak Kronzon, Carlos E. Ruiz, Gila Perk

Medication Adherence and Heart Failure

  • Ischemic Heart Disease (D Mukherjee, Section Editor)

Eric M. Riles, Anuja V. Jain, A. Mark Fendrick

Using Risk Prediction Tools in Survivors of In-hospital Cardiac Arrest

  • Ischemic Heart Disease (D Mukherjee, Section Editor)

Saket Girotra, Brahmajee K. Nallamothu, Paul S. Chan

Off-Pump Versus On-Pump Coronary Artery Bypass Grafting

  • Ischemic Heart Disease (D Mukherjee, Section Editor)

Christian H. Møller, Daniel A. Steinbrüchel

The Potential of FDG PET/CT for Early Diagnosis of Cardiac Device and Prosthetic Valve Infection Before Morphologic Damages Ensue

  • Nuclear Cardiology (V Dilsizian, Section Editor)

Wengen Chen, Jongho Kim, Olga P. Molchanova-Cook, Vasken Dilsizian

Cardiac PET-CT for Monitoring Medical and Interventional Therapy in Patients with CAD: PET Alone Versus Hybrid PET-CT?

  • Nuclear Cardiology (V Dilsizian, Section Editor)

Quynh A. Truong, Henry Gewirtz

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME